EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Globon Co. Ltd (019660) fair value: what the stock is really worth

As of Oct 2, 2026: fair value of Globon Co. Ltd KRW 228, price KRW 1,430, upside -84.1%, quality 36 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Consumer Non-Cyclicals · KR · ISIN KR7019660000

GC Thin data Sep 24, 2026

Globon Co. Ltd

019660 · KQ

Weakest SetupStrongly overvalued and low quality.

!Fair value 227.80 KRW · Strongly overvalued (−84.1%)
!Quality 36/100
!Weak Growth (revenue 5y +25.1 %/yr)
!Loss-making · -44.5% net margin (FY2026)
!Low debt · negative free cash flow
!Mixed vs. peers (3/7)
!Moderate moat 54/100
!Evidence only low, so the estimate is less certain
Watch Globon Co. Ltd for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

14,685 KRW 993.00 KRW Fair Value 227.80 KRW Apr 2021 Oct 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

60‑month range 993.00 KRW – 14,685 KRW · fair‑value band 170.00 KRW – 340.00 KRW · the 1,430 KRW price screens above the 227.80 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.

Follow Globon Co. in your weekly email

Every Wednesday you see whether Globon Co. is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Globon Co., Ltd. engages in wholesale and retail of cosmetics. It is also involved in manufacturing of cosmetic containers and products; and selling household goods to retail customers. In addition, the company engages in the gasification combined cycle power plant and investment businesses. The company was formerly known as Veritas Investment Co., Ltd.

Show more

Globon Co., Ltd. engages in wholesale and retail of cosmetics. It is also involved in manufacturing of cosmetic containers and products; and selling household goods to retail customers. In addition, the company engages in the gasification combined cycle power plant and investment businesses. The company was formerly known as Veritas Investment Co., Ltd. and changed its name to Globon Co., Ltd. in December 2015. Globon Co., Ltd. was founded in 1986 and is headquartered in Seoul, South Korea.

Stock analysis

Globon Co. Ltd (019660) currently trades at 1,430 KRW, while our model-based Fair Value estimate is 227.80 KRW, 84.1% below the price, so the stock looks overvalued today.

Show more

Valuation

How firm this estimate is: it rests on 1 models at a data quality of 96/100, which puts the evidence level at low.

Scenario range: 170.00 KRW (bear) to 340.00 KRW (bull), the price of 1,430 KRW sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 36/100 (below-average quality), in the Consumer Non-Cyclicals sector.

Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.

Globon Co. Ltd reported revenue of 12.9B KRW in FY2026 versus 5.2B KRW in FY2022, a compound +25.7%/yr. Reported net income was −5.8B KRW in FY2026.

Key figures

Market cap 26.8B KRW (≈ $19.9M) · P/S ratio 7.90 · Net margin −44.5% · Return on equity 221% · Return on assets (EBIT) −16.1% · Operating margin −290% · Revenue growth (YoY) +16.5% · Free cash flow −4.2B KRW.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (low confidence).

What moves the price

The share trades about 53% below its 52-week high and at its 52-week low, currently below its 200-day average.

For context, the median of 10 Consumer Non-Cyclicals peers we cover trades at −20% fair-value upside, at −84%, 019660 screens richer than that median.

Fair Value models

Bear 170.00 KRW Fair Value 227.80 KRW Bull 340.00 KRW
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
NCAV (Graham) 185.75 KRW 248.90 KRW 371.49 KRW 54
All 1 models by family
Asset-Based
NCAV (Graham) 185.75 KRW 248.90 KRW 371.49 KRW 54

Open the full fair value analysis →

Notify me when 019660 reaches fair value

Put 019660 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 36/100

Of which business quality 34 · Market factors (momentum, volatility) 20

Profitability 8
Margins and returns on capital today
Quality Growth 0
Are margins and returns improving?
Cashflow 4
Earnings quality: real cash, not paper profit
Fin. Strength 68
Balance sheet, leverage, solvency risk
Investment 100
Disciplined investing over empire-building
Low Volatility 56
Calm price path (market factor)
Momentum 8
Price trend over the last 3–12 months (market factor)
52W Momentum 0
Distance to the 52-week high (market factor)
Net Issuance 50
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 40/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
−25.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−11.2%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+25.1%
Start year 2021 (pandemic). Over 10 years: +5.3% a year
Revenue growth 24 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+13.6%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−106.4% (2021) → −36.9% (2026)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2026 is a loss year, no rate is defined from a loss
not computed

019660 screens overvalued: fair value 84% below the price. Compare with NeoPharm CO., LTD. →

Compare Globon Co. Ltd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its sector: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median. (Industry “Personal & Household Products & Services” was too small, so the broader sector is used.)Financials · 3205 stocks

Beats the sector median on 2/6 measures
Overall it trails its sector peers.
Valuation
Quality Score 34 · Bottom 25%
Fair Value upside −84.1% · Bottom 25%
Profitability
Return on equity (TTM) 221.0% · Top 25%
Return on assets −16.2% · Bottom 25%
Net margin (TTM) −44.5% · Bottom 25%
Growth and dividend
Revenue growth 16.5% · Above median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 25
FUTURE (revenue growth)83 · sector 47
PAST (return on equity)100 · sector 38
HEALTH (low debt)100 · sector 87
DIVIDEND (yield)0 · sector 59

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Personal & Household Products & Services stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
NeoPharm CO., LTD. 092730 23,100 KRW 28,699 KRW +24%
HYUNDAI BIOLAND Co 052260 5,200 KRW 2,383 KRW −54%
AUX AUX 1.24 PLN 0.3600 PLN −71%
FB FB 44.40 PHP 35.45 PHP −20%
JGS JGS 19.10 PHP 20.28 PHP +6%
URC URC 59.20 PHP 39.44 PHP −33%
SMC SMC 61.00 PHP 38.69 PHP −37%
MONDE MONDE 6.07 PHP 0.6600 PHP −89%
PGOLD PGOLD 39.20 PHP 48.56 PHP +24%
CNPF CNPF 32.20 PHP 56.26 PHP +75%

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Globon Co. Ltd · Fair Value
227.80 KRW −84%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "Globon Co. Ltd Fair Value". https://www.fairvalue-calculator.com/stock/019660

Frequently asked questions

Is Globon Co. Ltd (019660) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 227.80 KRW versus a price of 1,430 KRW, about −84% upside (overvalued).
What is the fair value of 019660?
Our model-based fair value for Globon Co. Ltd is 227.80 KRW (as of Sep 24, 2026), built from audited fundamentals. The current price: 1,430 KRW.
What is the quality score of 019660?
Globon Co. Ltd has a Quality Score of 36/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Globon Co. Ltd (019660)?
Our model-based price target is the fair value of 227.80 KRW (as of Sep 24, 2026) from 1 valuation models. Cautious scenario 170.00 KRW, optimistic scenario 340.00 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the Globon Co. Ltd stock forecast for 2026?
Our models put fair value at 227.80 KRW, about −84% upside versus a price of 1,430 KRW (overvalued). Cautious scenario 170.00 KRW, optimistic scenario 340.00 KRW. The calculation is refreshed regularly with new filings.
What is the intrinsic value of Globon Co. Ltd (019660)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Globon Co. Ltd it is 227.80 KRW per share (as of Sep 24, 2026), against a price of 1,430 KRW. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Globon Co. Ltd stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 019660 trades above its calculated fair value: price 1,430 KRW, fair value 227.80 KRW, a gap of about −84% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 019660?
No. The price is what the market pays today (1,430 KRW); the fair value is what the company's own numbers justify (227.80 KRW). For Globon Co. Ltd the two are 1,202 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Globon Co. Ltd worth?
The market values Globon Co. Ltd at about 26.8B KRW (market capitalisation, as of Sep 24, 2026). Per share that is 1,430 KRW; our models calculate a fair value of 227.80 KRW per share.
What do the bullish and bearish scenarios say about 019660?
Our models span a range for Globon Co. Ltd: cautious scenario 170.00 KRW, base 227.80 KRW, optimistic 340.00 KRW per share (as of Sep 24, 2026, price 1,430 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Globon Co. Ltd (019660)?
Balance-sheet figures for Globon Co. Ltd (as of Sep 24, 2026): return on equity 221.0%. They feed the Quality Score of 36/100, which measures business quality independently of the share price.
How far is 019660 from its 52-week high?
Globon Co. Ltd trades at 1,430 KRW, about 53% below its 52-week high of 3,055 KRW and at the low of 1,430 KRW (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of 227.80 KRW is for.
Which stocks are comparable to Globon Co. Ltd?
From the same area (Consumer Non-Cyclicals) we also value NeoPharm CO., LTD., HYUNDAI BIOLAND Co, AUX, FB, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Globon Co. Ltd stock attractive at the current price?
The data as of Sep 24, 2026: price 1,430 KRW, calculated fair value 227.80 KRW (−84%), Quality Score 36/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 019660 calculated?
We run Globon Co. Ltd through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 227.80 KRW, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Globon Co. Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Globon Co. Ltd (019660)?
The closing price on Oct 2, 2026 was 1,430 KRW. Our model-based fair value is 227.80 KRW, about −84% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Globon Co. Ltd right now?
The price sits above even our optimistic bull case (340.00 KRW). The favourable scenario is already priced in. Weak quality (36/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range (170.00 KRW to 340.00 KRW) leaves room in how you read the outcome.

Key figures of Globon Co. Ltd

How large is the market capitalisation of Globon Co. Ltd (019660)?
The market capitalisation of Globon Co. Ltd is 26.8B KRW (≈ $19.9M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Globon Co. Ltd (019660)?
The price-to-sales ratio of Globon Co. Ltd is 7.90 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of Globon Co. Ltd (019660)?
The net margin of Globon Co. Ltd is −44.5% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Globon Co. Ltd (019660)?
The return on equity (ROE) of Globon Co. Ltd is 221% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Globon Co. Ltd (019660)?
On an EBIT basis the return on assets of Globon Co. Ltd is −16.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Globon Co. Ltd (019660)?
The operating margin of Globon Co. Ltd is −290% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Globon Co. Ltd (019660)?
Revenue at Globon Co. Ltd is growing +16.5% versus a year earlier (3y avg −11.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Globon Co. Ltd (019660) generate?
The free cash flow of Globon Co. Ltd is −4.2B KRW (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Globon Co. Ltd (019660) carry?
The net debt of Globon Co. Ltd is 3.5B KRW (fiscal year 2026). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Globon Co. Ltd in the live analysis

One click puts Globon Co. Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.